Erasca, Inc. (ERAS) Form 8-K — Aug 10, 2026

$ERASForm 8-KItems 5.02Filed Aug 10, 2026, 5:14 PM ET0001193125-26-342669Original filing

Erasca, Inc. appointed Dr. Charles S. Fuchs as President, Research & Development, effective August 10, 2026, per an 8-K filed under Item 5.02.

Key figures

Annual Base Salary: $570,000
Stock Options Granted: 1300000
Option Vesting Schedule: 4 years, 25% cliff at first anniversary, remainder monthly
Target Bonus Percent Of Base: 45
Options Under Inducement Plan: 1278520
Inducement Plan Shares Reserved: 6200000

1 day: +1.6%7 days: +0.9%30 days: -10.2%

Close on the filing date to close N calendar days later (from $18.12). Historical, not a forecast.

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.